ONC Q4 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q4 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$18M

Gross Profit

-$76M-419.3% margin

Operating Income

-$104M-571.1% margin

Net Income

-$99M-546.5% margin

EPS (Diluted)

$-2.21

QoQ Revenue Growth

-91.7%

Cash Flow

Operating Cash Flow

$94M

Free Cash Flow

$75M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$362M

Stockholders' Equity

$684M

Cash & Equivalents

$240M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$0	—
Gross Profit	-$76M	-$29M	-163.4%
Operating Income	-$104M	-$37M	-178.5%
Net Income	-$99M	-$38M	-164.2%